Bone Growth Stimulator Market Analysis 2026

Current Scenario of Bone Growth Stimulator Market

The key opportunity of Bone growth stimulator market

• Technological advancements act as an opportunity for the market

The creation of more sophisticated, effective, and user-friendly devices is made possible by technological breakthroughs, which support the market's expansion.  Furthermore, cutting-edge technologies that promote bone regeneration, such as pulsed electromagnetic fields (PEMF), ultrasound, and electromagnetic fields, are incorporated into contemporary bone growth stimulators.  For example, Electromagnetic fields are used in pulsed electromagnetic field (PEMF) therapy to treat a variety of physiological dysfunctions, including slow-healing wounds and fractures. It has also been demonstrated to help with pain relief, inflammation reduction, sleep and relaxation, and circulation improvement. PEMF is utilized by 4,000 athletes in Europe and a large number of athletes in the United States, and it has been certified for use by the International Olympic Committee for use by human and equestrian (horse) athletes.

Source (https://vitality-pro.com/biohacking/pemf/statistics-trends/#:~:text=into%20the%20future.-,PEMF%20Stats%20%26%20Trends%20For%202022%20and%202023,reach%20%24781.94%20million%20by%202028.)

For example, The EXOGEN Ultrasound Bone Healing System is used for non-invasive treatment of established non-union, excluding skull and vertebra. It is effective as an adjunctive treatment in patients with internal or external fracture fixation hardware, ongoing infection treatment, or diminished bone quality. It accelerates the time to heal fractures in skeletally mature individuals. However, safety and effectiveness are not established for individuals lacking skeletal maturity, pregnant or nursing women, cardiac pacemakers, bone cancer patients, or those with poor blood circulation or clotting problems.

Source (https://www.exogen.com/en/)

Aside from this, better gadget functionality and design improve patient compliance while also improving treatment outcomes. Additionally, the market is growing because patients are using smaller, more portable devices with advanced control more frequently since they can integrate them into their regular routines. 
Healthcare professionals are looking for practical, research-backed solutions for their patients in line with this. Furthermore, the industry is expanding due to the general public's growing need for more appealing and successful treatment options. 
Moreover, the development of sophisticated bone growth stimulators with wireless connectivity allows medical professionals to keep an eye on treatment progress and patient compliance from a distance.

Key Drivers of the Bone Growth Stimulator Market

Increasing preferences for non-invasive treatment solutions acts as a driver

The market is expanding as a result of patients' growing desire for non-invasive, painless treatment options. Accordingly, patients are looking for less invasive and surgical options more and more. Bone growth stimulators also offer a non-surgical means of promoting bone repair. The US is expected to dominate the North American region by garnering maximum sales in the global Bone Growth Stimulators market. According to the CDC, around 1 out of every 4 US adults (23.7%, 58.5 million people) suffer from diagnosed arthritis. The incidence of arthritis and osteoarthritis is predicted to grow in the forthcoming years, which in turn will propel the demand for electrical Bone Growth Stimulators over the assessment period.

Source(https://www.pharmiweb.com/press-release/2023-08-21/bone-growth-stimulators-projected-to-reach-us-54-billion-by-2033-with-impressive-101-cagr-surge)

In addition, non-invasive procedures lessen the chance of complications and infection while also easing patient discomfort. This is why a wide range of patients, including those who are afraid of surgery or are not suitable candidates for invasive operations, find bone growth stimulators very enticing.  Also, non-invasive therapies frequently result in quicker recovery periods, enabling patients to get back to their regular activities sooner. As well, the industry is growing because of the increased emphasis on patient-centric approaches. Furthermore, non-invasive treatments are more economical than surgical procedures since they use fewer hospital resources, result in shorter hospital stays, and lower overall healthcare costs. All of these factors are driving the market.

• The rising incidence of bone and joint disorders is driving the market growth 

The market for bone growth stimulators is primarily driven by factor of increasing prevalence of bone and joint problems. Osteoarthritis, a common articular illness affecting people over 65, is a significant concern. For example, The CDC estimates that 63 million Americans currently have a diagnosis of arthritis, which is expected to rise to 78 million by 2040. 

Source (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059375/#:~:text=By%202040%2C%20the%20number%20of,11.4%25%20of%20all%20adults) 

The market is expected to rise positively as a result of the increasing use of bone growth stimulators brought on by an increase in the number of bone fractures among people.  Globally, in 2019, there were 178 million new fractures, 455 million prevalent cases of acute or long-term symptoms of a fracture 

Source (https://pubmed.ncbi.nlm.nih.gov/34723233/#:~:text=Findings%3A%20Globally%2C%20in%202019%2C,65%C2%B73%25%20%5B62%C2%B7)

Accordingly, a variety of events, including accidents, sports injuries, and aging-related conditions, can result in bone fractures. The market is expanding because older people are using bone growth stimulators more frequently since their lower bone density makes them more vulnerable to fractures.  In addition, bone growth stimulators are a popular option for patients and healthcare providers alike because they provide a workable way to promote faster and more efficient bone healing.  Furthermore, patients' growing emphasis on improved treatment options is driving market expansion. In addition, compared to conventional fracture treatments, bone growth stimulators help with quicker healing and less discomfort, which is why more and more individuals are choosing them. Moreover, the growing patient desire for superior care is supporting the market expansion.

Key restraints of the Bone growth stimulator market

• Limited medication adherence among patients’ high burden to limit market growth 

Medication adherence is primarily the responsibility of the patient, and effective patient education is crucial for improving this. A study found that education of both the patient and physician was associated with improved blood pressure control compared to the physician alone.  A good physician-patient relationship is essential for medication adherence. Physicians can use a patient-centered approach to care, promoting active patient involvement in the medical decision-making process. Many patients with chronic illnesses have difficulty adhering to their recommended medication regimen. Believing that medication nonadherence is the “fault” of the patient is an uninformed and destructive model that is best abandoned. Healthcare systems must evolve to emphasize medication adherence, and time constraints may be addressed by developing a team-based approach to healthcare. Increasing product launches have also surged the number of product recalls worldwide, thereby hindering market growth to a certain extent. 

How did COVID-19 impact the Bone growth stimulator market

The COVID-19 pandemic has significantly impacted the orthopedic-related market, including the bone growth stimulator market. Postponed elective surgeries, clinic closures, and a ban on organized sports have led to a decline in the market. The Centers for Medicare & Medicaid Services (CMS) announced that all non-essential medical, surgical, elective, and dental procedures had been postponed.  Over 6.3 million elective orthopedic surgeries were canceled globally during the pandemic's peak disruption. However, this deferral of care likely resulted in a significant backlog of future patient demand.  A study by the Journal of Bone and Joint Surgery suggested that the U.S. may face a cumulative backlog of over a million spine surgery and joint replacement cases by mid-2022, requiring up to 16-18 months to work through. This backlog of orthopedic procedures could support market growth shortly.

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Bone Growth Stimulator Market is witnessing significant growth in the near future.

In 2023, the Device segment accounted for noticeable share of global Bone Growth Stimulator Market and is projected to experience significant growth in the near future.

The Spinal Fusion Surgeries segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies DJO Finance , Stryker Corporation and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)